Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis

• 作 者: Ahmed Alzamzamy Huda Elsayed Mona Abd Elraouf Hanan Eltoukhy Tarek Megahed Ashraf Aboubakr
• 机 构: DepartmentofGastroenterologyandHepatology,DepartmentofGastroenterologyandHepatology,DepartmentofInte
• 出 处: 世界胃肠肿瘤学杂志:英文版(电子版)
• 发表日期: 2021年6期
• 关键词: Hepatocellular carcinoma Vascular endothelial growth factor Biomarkers DIAGNOSIS
• 基金项目: The study was reviewed and approved by(Egypt Center for research and regenerative medicine,and Al Azhar University)Institutional Review Board,No.IRB 00012517.

BACKGROUND Hepatocellular carcinoma(HCC)accounts for 8.2%of all cancer-related deaths worldwide.Being a vascular tumor,vascular endothelial growth factor(VEGF)plays a vital role in HCC pathogenesis,growth,and spread.AIM To determine the accuracy of serum